Kiran Kancherla

Nepean Hospital — Australia

Physics and Astronomy · Physical Sciences

13h-index1.6kcitations23works35.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Radiotherapy Techniques(9), Prostate Cancer Treatment and Research(7), Prostate Cancer Diagnosis and Treatment(6), Cancer-related cognitive impairment studies(3), Glioma Diagnosis and Treatment(2)

Publications20 total

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial
The Lancet Oncology·2025· 20 citedOpen Access
The Role of Vitamin C in Wound Healing in Surgically Managed Diabetic Foot Disease
Diabetology·2025· 1 citedOpen Access
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer
New England Journal of Medicine·2024· 174 citedOpen Access
279P Incidence, risk factors and management of medication-related osteonecrosis of the jaw in breast cancer patients treated with zoledronic acid or denosumab over a 5-year period in a UK tertiary institution
ESMO Open·2024· 2 citedOpen Access
3395: Acute toxicity from PACE-C comparing Stereotactic Body Radiotherapy (SBRT) with moderate hypofractionation (MHRT)
Radiotherapy and Oncology·2024· 3 cited
Involvement of single nucleotide polymorphisms of junction adhesion molecule with small vessel vascular dementia
Aging Medicine·2023· 3 citedOpen Access
5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2023· 49 cited
Iron-induced Hypophosphatemic Osteomalacia—An Atypical Case of Bilateral Femoral Stress Fractures
JAAOS Global Research and Reviews·2023· 2 citedOpen Access
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
The Lancet Oncology·2022· 281 citedOpen Access
Therapeutic mammoplasty is associated with fewer long-term side-effects from breast radiotherapy
European Journal of Surgical Oncology·2022
OC-0289 Comparison of side effects at 2 years in the randomised PACE-B trial (SBRT vs standard radiotherapy)
Radiotherapy and Oncology·2021· 4 cited
Assessing the benefits and toxicities of platinum containing neoadjuvant chemotherapy in triple negative breast cancer
European Journal of Cancer·2020
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
The Lancet Oncology·2019· 519 citedOpen Access
Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial
PLoS ONE·2018· 57 citedOpen Access
Effects of a self-managed home-based walking intervention on psychosocial health outcomes for breast cancer patients receiving chemotherapy: a randomised controlled trial
Supportive Care in Cancer·2015· 110 citedOpen Access
Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol
BMC Public Health·2015· 25 citedOpen Access
Radiotherapy for Node Positive Penile Cancer: Experience of The Leeds Teaching Hospitals
The Journal of Urology·2011· 80 cited
A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer
Radiation Oncology·2010· 30 citedOpen Access
The Role of Split-course Hypofractionated Palliative Radiotherapy in Head and Neck Cancer
Clinical Oncology·2010· 48 cited
560 ADJUVANT NODAL RADIOTHERAPY IN SQUAMOUS CELL CARCINOMA OF THE PENIS
European Urology Supplements·2010

Frequent Co-authors

Alison Tree(7), Shaun Tolan(7), Olivia Naismith(7), Nicholas van As(7), Peter Ostler(6), H. van der Voet(6), William Chu(6), Stephanie Brown(6), Stephanie Burnett(6), Clare Griffin(6), Douglas Brand(5), Andrew Loblaw(5), Daniel Ford(5), Suneil Jain(5), John Staffurth(5), Philip Camilleri(5), J. Frew(5), Emma Hall(5), Anthony T.�C. Chan(4), Ian S. Dayes(4)